Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.39 |
| ▸ | CHRM5 | P08912 | 5/20 | 0.37 |
| ▸ | CHRM3 | P20309 | 5/20 | 0.37 |
| ▸ | CHRM2 | P08172 | 5/20 | 0.37 |
| ▸ | CHRM1 | P11229 | 4/20 | 0.37 |
| ▸ | CHRM4 | P08173 | 4/20 | 0.37 |
| ▸ | CHRNB2 | P17787 | 2/20 | 0.36 |
| ▸ | CHRNA4 | P43681 | 2/20 | 0.36 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.36 |
| ▸ | ADRA2A | P08913 | 1/20 | 0.34 |
| ▸ | ADRA2B | P18089 | 1/20 | 0.34 |
| ▸ | ADRA2C | P18825 | 1/20 | 0.34 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL4787170 | 0.98 | L3MBTL1 (0.38) | L3MBTL1CHRM5CHRM3CHRM2CHRM1 | |
| SCHEMBL20878701 | 0.94 | MEN1 (0.38) | L3MBTL1CHRM5CHRM3CHRM2CHRM1 | |
| SCHEMBL11742539 | 0.93 | ADRA2A (0.40) | L3MBTL1CHRM5CHRM3CHRM2CHRM1 | |
| SCHEMBL27490115 | 0.69 | — | — | |
| SCHEMBL11740603 | 0.69 | — | — | |
| SCHEMBL471865 | 0.69 | ADRA2A (0.44) | ADRA2AADRA2BADRA2CADRA1A | |
| SCHEMBL961726 | 0.69 | ADRA2A (0.44) | ADRA2AADRA2BADRA2CADRA1A | |
| SCHEMBL19612832 | 0.68 | — | — | |
| SCHEMBL11743173 | 0.68 | ADRA2A (0.38) | ADRA2AADRA2BADRA2CADRA1A | |
| SCHEMBL2778023 | 0.68 | ADRA2A (0.38) | ADRA2AADRA2BADRA2CADRA1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4667231-A1 | PRETREATMENT LIQUID FOR INKJET INK, INK SET, IMAGE RECORDING METHOD, LAMINATE MANUFACTURING METHOD, IMAGE RECORDED MATTER, AND LAMINATE | FUJIFILM Corporation (JP) | 2025-12-24 | — | — | EP | disclosed |
| US-20250368847-A1 | PRETREATMENT LIQUID FOR INK JET INK, INK SET, IMAGE RECORDING METHOD, METHOD OF PRODUCING LAMINATE, IMAGE RECORDED MATERIAL, AND LAMINATE | FUJIFILM CORPORATION (JP) | 2025-12-04 | — | — | US | disclosed |
| US-20250129259-A1 | INK SET FOR INKJET TEXTILE PRINTING, IMAGE FORMING METHOD, AND IMAGE FORMED PRODUCT | Konica Minolta, Inc. (JP) | 2025-04-24 | — | — | US | disclosed |
| WO-2024171668-A1 | PRETREATMENT LIQUID FOR INKJET INK, INK SET, IMAGE RECORDING METHOD, LAMINATE MANUFACTURING METHOD, IMAGE RECORDED MATTER, AND LAMINATE | 富士フイルム株式会社 | 2024-08-22 | — | — | WO | disclosed |
| US-10968176-B2 | Pyrrolidone derivatives, oligomers and polymers | NANOSYNTHONS LLC (US) | 2021-04-06 | — | — | US | disclosed |
| US-20190352258-A1 | PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS | NANOSYNTHONS LLC (US) | 2019-11-21 | — | — | US | disclosed |
| EP-2592120-B1 | AQUEOUS INKJET INK, AND METHOD FOR FORMING INKJET IMAGE | KONICA MINOLTA HOLDINGS INC (JP) | 2017-08-02 | — | — | EP | disclosed |
| US-9062223-B2 | Aqueous inkjet ink and method for forming inkjet image | Konica Minolta, Inc. (JP) | 2015-06-23 | — | — | US | disclosed |
| US-20130106945-A1 | AQUEOUS INKJET INK AND METHOD FOR FORMING INKJET IMAGE | KONICA MINOLTA HOLDINGS, INC. (JP) | 2013-05-02 | — | — | US | disclosed |
| CN-101056868-B | Substituted chroman derivatives, medicaments and use in therapy | MARSHALL EDWARDS INC | 2012-05-02 | — | — | CN | disclosed |
| CN-100408574-C | Nicotinic acid-heterocyclyl-amides and analogous pyrimidine derivatives serving as pesticides | BAYER CROPSCIENCE GMBH (DE) | 2008-08-06 | — | — | CN | disclosed |
| CN-101133022-A | Substituted 2-pyrrolidone derivatives as fungicides and insecticides | BAYER CROPSCIENCE AG (DE) | 2008-02-27 | — | — | CN | disclosed |
| CN-101102991-A | Method for the production of optically active cyclic amines | BAYER CROPSCIENCE AG (DE) | 2008-01-09 | — | — | CN | disclosed |
| CN-1653048-A | Pyridinecarboxamide derivatives and their use as pesticides | BAYER CROPSCIENCE GMBH (DE) | 2005-08-10 | — | — | CN | disclosed |
| CN-1653049-A | Pesticidal pyridine carboxamide derivatives | BAYER CROPSCIENCE GMBH (DE) | 2005-08-10 | — | — | CN | disclosed |
| US-6451727-B2 | PREPARED FROM CHIRAL AMINO ALCOHOLS; SUITABLE FOR ASSYMETRIC CATALYSIS; FOR TRANSFER HYDROGENATION OF KETONES AND IMINES; ENANTIOMORPHS; PURITY; EFFICIENCY | THE PENN STATE RESEARCH FOUNDATION | 2002-09-17 | — | — | US | disclosed |
| US-20010044546-A1 | Prepared from chiral amino alcohols; suitable for assymetric catalysis; for transfer hydrogenation of ketones and imines; enantiomorphs; purity; efficiency | THE PENN STATE RESEARCH FOUNDATION | 2001-11-22 | — | — | US | disclosed |
| US-6255493-B1 | REACTING IMIDATE ESTER WITH CHIRAL ALCOHOL IN PRESENCE OF TRANSITION METAL CATALYST TO FORM BIS(4-(R)-PHENYLOXAZOLIN-2-YL-METHYL)AMINE LIGANDS; USE TO MAKE RUTHENIUM CATALYST FOR TRANSFER HYDROGENATION | THE PENN STATE RESEARCH FOUNDATION | 2001-07-03 | — | — | US | disclosed |
| EP-1030849-A1 | TRANSITION METAL-CATALYZED REACTIONS BASED ON CHIRAL AMINE OXAZOLINYL LIGANDS | The Pennsylvania State University (US) | 2000-08-30 | — | — | EP | disclosed |
| WO-1999024410-A1 | TRANSITION METAL-CATALYZED REACTIONS BASED ON CHIRAL AMINE OXAZOLINYL LIGANDS | THE PENN STATE RESEARCH FOUNDATION (US) | 1999-05-20 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010044546-A1 | Prepared from chiral amino alcohols; suitable for assymetric catalysis; for transfer hydrogenation of ketones and imines; enantiomorphs; purity; efficiency | AADAT, ADH1C, ADH5 | L3MBTL1 4377/4885CHRM5 3398/4885CHRM3 1880/4885 |
| US-10968176-B2 | Pyrrolidone derivatives, oligomers and polymers | POF1B, VGF, RAB5IF | L3MBTL1 670/4885CHRM5 4533/4885CHRM3 3478/4885 |
| US-20190352258-A1 | PYRROLIDONE DERIVATIVES, OLIGOMERS AND POLYMERS | POF1B, VGF, RAB5IF | L3MBTL1 670/4885CHRM5 4533/4885CHRM3 3478/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.